FTSE All-Share
5.576,38
PKT
-20,66
PKT
-0,37
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.10.12 | Glencore neutral | UBS AG | |
| 02.10.12 | BP outperform | Credit Suisse Group | |
| 02.10.12 | Diageo overweight | Morgan Stanley | |
| 02.10.12 | AstraZeneca hold | Deutsche Bank AG | |
| 02.10.12 | National Grid overweight | Morgan Stanley | |
| 02.10.12 | Glencore neutral | Sarasin Research | |
| 01.10.12 | Vodafone Group overweight | Morgan Stanley | |
| 28.09.12 | Vodafone Group overweight | J.P. Morgan Cazenove | |
| 28.09.12 | Rio Tinto outperform | Exane-BNP Paribas SA | |
| 28.09.12 | Vodafone Group underperform | Exane-BNP Paribas SA | |
| 28.09.12 | Anglo American neutral | Exane-BNP Paribas SA | |
| 28.09.12 | Antofagasta outperform | Exane-BNP Paribas SA | |
| 28.09.12 | Vodafone Group buy | ING | |
| 28.09.12 | Barclays buy | Citigroup Corp. | |
| 27.09.12 | Kingfisher neutral | J.P. Morgan Cazenove | |
| 27.09.12 | London Stock Exchange (LSE) overweight | HSBC | |
| 27.09.12 | Diageo outperform | Credit Suisse Group | |
| 27.09.12 | Kingfisher neutral | Nomura | |
| 26.09.12 | Diageo buy | UBS AG | |
| 26.09.12 | Unilever halten | Hamburger Sparkasse AG (Haspa) | |
| 26.09.12 | AstraZeneca overweight | Morgan Stanley | |
| 25.09.12 | BP buy | UBS AG | |
| 25.09.12 | Glencore neutral | Sarasin Research | |
| 25.09.12 | Diageo hold | ING | |
| 25.09.12 | Barclays buy | Société Générale Group S.A. (SG) | |
| 25.09.12 | Anglo American neutral | Sarasin Research | |
| 25.09.12 | Intertek hold | Société Générale Group S.A. (SG) | |
| 27.09.12 | Centrica underperform | Exane-BNP Paribas SA | |
| 24.09.12 | BP halten | Independent Research GmbH | |
| 24.09.12 | Glencore hold | Société Générale Group S.A. (SG) | |
| 21.09.12 | Imperial Brands buy | Société Générale Group S.A. (SG) | |
| 21.09.12 | Rio Tinto outperform | RBC Capital Markets | |
| 20.09.12 | Imperial Brands kaufen | Independent Research GmbH | |
| 20.09.12 | Vodafone Group overweight | Morgan Stanley | |
| 19.09.12 | AstraZeneca buy | UBS AG | |
| 19.09.12 | Barclays overweight | Morgan Stanley | |
| 19.09.12 | Kingfisher buy | Sarasin Research | |
| 18.09.12 | Glencore neutral | UBS AG | |
| 18.09.12 | Shell (ex Royal Dutch Shell) buy | ING | |
| 18.09.12 | Vodafone Group verkaufen | Independent Research GmbH |
